#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hairy cell leukaemia recurrent Frostbite Immunoglobulin G4 related disease Synovial sarcoma metastatic Mixed-type liposarcoma CDKL5 deficiency disorder Cystic fibrosis respiratory infection suppression Hormone-dependent prostate cancer Congenital growth hormone deficiency Prodromal Alzheimer's disease Neuroendocrine tumour Cutaneous T-cell lymphoma Anal fistula Anal cancer recurrent Follicular lymphoma More trials…

    Learn about Rare Diseases

    Brain stem glioma – Diagnostics Familial haemophagocytic lymphohistiocytosis – Life with Disease Hairy cell leukaemia – Trials in Disease Phenylketonuria – Life with Disease Glomerulonephritis membranous – Diagnostics Bronchiolitis obliterans syndrome – Life with Disease Glycogen storage disease type I – Life with Disease Ewing’s sarcoma metastatic – Basic Information Hereditary ataxia – Diagnostics Haemophagocytic lymphohistiocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clascoterone Tapderimotide Doxazosin Mesilate Latanoprost Camlipixant ZILEBESIRAN Eight Treg Citalopram Gs-4182 A52 Incb099280 Ascorbic Acid Cetuximab Imifoplatin Lucerastat Anhydrous Cyclophosphamide Bcmacp03 64Cu-Dota-Ae105 Aluminium Oxide Ptg-Carcik-Cd19 More therapies…

    Learn about Your Condition

    Erosive oesophagitis Hyperglycaemia Herpes simplex HER2 positive gastric cancer Myocardial infarction Peptostreptococcus infection Eyelid ptosis Vulvovaginal candidiasis Graft infection Normal pressure hydrocephalus Mitochondrial myopathy Atrophic vulvovaginitis Transferrin decreased Insomnia Juvenile psoriatic arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the safety and effectiveness of resomelagon in patients with polymyalgia rheumatica who are in remission using glucocorticoids

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Polymyalgia rheumatica
    Investigated Drugs:
    • Resomelagon
    Denmark

  • Study of the effectiveness and safety of tirzepatide for treating obesity in patients waiting for a liver transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Tirzepatide
    Czechia

  • Study of osimertinib and febuxostat to improve drug delivery in patients with EGFR-mutated non-small cell lung cancer without brain metastases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Febuxostat
    • Osimertinib
    The Netherlands

  • A study of ipilimumab and nivolumab to observe immune system changes in patients with unresectable stage III or IV melanoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage III
    • Malignant melanoma stage IV
    Investigated Drugs:
    • Ipilimumab
    The Netherlands

  • A study to evaluate if atorvastatin prevents gallstones in patients undergoing bariatric surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Atorvastatin
    The Netherlands

  • Evaluating the use of technetium (99mTc) galactosyl serum albumin to predict complications in patients undergoing surgery for liver tumors

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cancer
    Denmark
Previous Page
1 … 732 733 734 735 736 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!